Please take a minute out of whatever you’re doing to look at this bar graph:
Stunning, isn’t it? What this demonstrates is that even before the bottom fell out of the economy, almost nobody in the United States got a real raise during the Bush years. Between 1999 and 2008, employer-sponsored health insurance premiums increased six times faster than wages. Average employer contributions to family health care plans more than doubled, and so did average worker contributions to those plans. Whatever pay increases the average worker received were wiped out, and then some, by the rapidly growing amounts deducted from his paycheck to cover health insurance. That’s assuming he was lucky enough to be among the 59 percent of the U.S. population that received employment-based health insurance. (Fifteen percent have no health insurance at all. The other 26 percent either buy their own health insurance or get it through government programs like Medicare and Medicaid.) These calculations don’t take into account the rising cost of actually using ever-pricier health coverage. During the same period, deductibles tripled.
Health care costs have spiraled out of control. That, in a nutshell, is why Congress and the Obama administration must enact health care reform.
Now consider the following calculations, from an April 6 study by the Lewin Group, a private health care research-and-consulting firm in Falls Church, Va. If, as part of health care reform, the federal government were to create a new health insurance program to compete with private insurers—as candidate Obama called for during the presidential campaign—and if that plan were to provide the same payment levels as Medicare does, then the premiums families would pay to participate would be 30 percent to 40 percent less than those paid by families to participate in a comparable private plan. Medicare, because it represents about 20 percent of the entire health care market and because its administrative costs are about one-third those of private health insurers, is able to pay hospitals roughly 30 percent less than what private insurers pay and to pay doctors roughly 20 percent less. Alternatively, if the new government health insurance program were to match what private insurers paid hospitals and doctors—an option I consider needlessly wasteful of taxpayer dollars—then its premiums would still,because of its lower administrative costs, be about 9 percent less than those of comparable private health insurance plans.
The very simplicity and directness of the public option is its biggest political liability. It’s a little too obvious that creating a new health insurance program would harm private insurers. The Lewin Group calculates that if, as Obama proposed during the campaign, large employers were excluded from participating in the plan, then private insurers would lose about 19 percent of their customers. If large employers were not excluded—and I see no logical reason why they should be—then private insurers would lose about 70 percent of their customers. To my mind, private insurers would be left with a solid boutique market (51 million people) for which they ought to be grateful. But, of course, private insurers can’t abide that possibility and will likely do everything in their power to eliminate the public option from health care reform.
Instead, the health insurance industry proposes keeping costs down through a variety of indirect means. Some of these (more electronic recordkeeping, more preventive care, tighter restrictions on malpractice litigation) would be worthwhile even if they didn’t save money. Other methods risk creating more problems than they solve. But the bottom line is that the insurers’ basket of proposals would not, even by their own reckoning, cut health care costs; instead, they would cut the rate of growth in health care spending by 6 percent to 7 percent.
One of the insurers’ ideas to cut spending is the establishment of a “comparative effectiveness board,” which would collect clinical data on the comparative effectiveness of drugs, devices, procedures, and therapies and distribute this information to patients and doctors. This information would be used to alter “payment incentives” to “encourage value-based purchasing.” It’s a very popular idea in health-reform circles. Candidate Obama’s health care plan similarly proposed building on existing “efforts to develop and disseminate best practices, and align reimbursements with provision of high quality health care.” In an April 10 Washington Post column, Steven Pearlstein wrote that any public option must pay for care “on the basis of the quality of the outcome.” In their new book, The Next Progressive Era: A Blueprint for Broad Prosperity, Phillip Longman and Ray Boshara go so far as to argue that the establishment of “truly evidence-driven protocols” might potentially “cut American health care spending by a third.”
It’s difficult to be against anything that promotes “quality,” and compiling better information about what works and what doesn’t is obviously worthwhile. But one lesson of No Child Left Behind, the national education-standards reform implemented by President George W. Bush, is that protocols can be imposed so ham-handedly that they snuff out creativity and eliminate the possibility of treating the individuals they’re meant to help as, well, individuals. This in a realm—deciding what children should learn—that’s simple and straightforward compared with deciding how best to treat the sick. In an April 8 Wall Street Journal op-ed, Jerome Groopman and Pamela Hartzband argued that government regulators have already begun to overreach on “quality metrics.” They cited as an example a widely used protocol requiring hospital intensive-care units to keep the blood sugar of critically ill patients below a certain level. A medical colleague of Groopman’s and Hartzband’s in Massachusetts, which adopted this protocol, told them “how his care of the critically ill is closely monitored”:
If his patients have blood sugars that rise above the metric, he must attend what he calls “re-education sessions” where he is pointedly lectured on the need to adhere to the rule. If he does not strictly comply, his hospital will be downgraded on its quality rating and risks financial loss. His status on the faculty is also at risk should he be seen as delivering low-quality care.
In March, the New England Journal of Medicine published a study of 6,000 critically ill ICU patients that suggested the protocols had it exactly wrong—survival rates for patients whose doctors followed the blood-sugar protocol were lower than those for patients whose doctors ignored the protocol. “Human beings are not uniform in their biology,” Groopman and Hartzband explained. “A disease with many effects on multiple organs, like diabetes, acts differently in different people.” Moreover, “Medicine is an imperfect science,” and the best-available information about treatments is subject to frequent change.
Obviously, there’s great potential value in having the government compile information about best medical practices and even in using that information to impose guidelines. Strict rules about obvious things like hand-washing have been implemented to good effect. But, in general, quality standards must be applied with sufficient flexibility to take into account the human variety and medical uncertainty that Groopman and Hartzband discussed. Where to draw the line is a question well beyond my inexpert understanding of medicine, but it seems a good bet that using quality metrics with the goal of pushing costs down, as opposed to improving patient care, would create just the regimentation Groopman and Hartzband fear. Cutting U.S. health care spending by one-third through the use of evidence-driven protocols, as Longman and Boshara believe possible, would surely inhibit physician care to the serious detriment of patients’ health. (Their book’s other proposals for reforming health care, especially the creation of a civilian hospital network modeled on the Veterans Administration, are much more persuasive. I should probably note here that Groopman, Hartzband, and Longman are all friends of mine.)
If you really want to rein in health care costs, then consensus reform options like creating a comparative effectiveness board won’t get you very far. For the true spending hawk, I see no practical alternative to the “socialist” public option.
[Update, April 13: In his invaluable health care blog, “The Treatment,” on the New Republic’s Web site, Jonathan Cohn touts a new article in Annals of Internal Medicine by Theodore Marmor, Jonathan Oberlander, and Joseph White. Marmor et al. are, like me, skeptical about the possibility of achieving significant cost control with the less-controversial health reform proposals under consideration. Preventive care, they say, typically adds to spending, and “we lack evidence that paying providers on the basis of outcomes will reduce spending on medical care.” The financial benefit from electronic medical records is also oversold, they argue, a point Groopman and Hartzband also made in a March Wall Street Journal op-ed.]